Not Medicare Enrolled

Dr. Peter McCullough, MD, MPH

Cardiovascular Disease · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
3409 WORTH ST STE 500, Dallas, TX 75246
2148412000
Registered in NPPES since 2006
NPI: 1386604700 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McCullough from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCullough? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McCullough

Dr. Peter McCullough is a cardiovascular disease specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. McCullough performed 36 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. McCullough received a total of $969,658 from 60 pharmaceutical and/or device companies across 1069 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McCullough is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 36 Medicare services $969,658 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
36
Medicare services
Bottom 2% in TX for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 22 $33 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 14 $85 $220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$969,658
Total received (2018-2024)
Avg $138,523/year across 7 years
Top 0% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,069
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$405
2023
$3,239
2022
$20,802
2021
$93,178
2020
$183,831
2019
$362,280
2018
$305,924

Payments by company (2024)

Merck Sharp & Dohme LLC
$161
Corium, LLC
$47
Corcept Therapeutics
$33
Novo Nordisk Inc
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Novartis Pharmaceuticals Corporation
$18
AstraZeneca Pharmaceuticals LP
$18
IDORSIA PHARMACEUTICALS US INC
$17
Azurity Pharmaceuticals, Inc.
$16
SANOFI-AVENTIS U.S. LLC
$15
Amgen Inc.
$15
ABBVIE INC.
$14
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 59.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$181,973
SANOFI-AVENTIS U.S. LLC
$116,500
Amgen Inc.
$101,180
Merck Sharp & Dohme Corporation
$57,892
Edwards Lifesciences Corporation
$45,989
Novo Nordisk Inc
$43,336
Regeneron Healthcare Solutions, Inc.
$40,635
Janssen Pharmaceuticals, Inc
$40,180
Novo Nordisk AS
$40,000
Bayer HealthCare Pharmaceuticals Inc.
$35,983
AstraZeneca AB
$22,740
AKEBIA THERAPEUTICS INC
$17,980
SANOFI US SERVICES INC.
$17,674
NxStage Medical, Inc.
$17,664
Otsuka Pharmaceutical Co., Ltd.
$17,364
Lilly USA, LLC
$15,336
GE HEALTHCARE
$15,313
Abbott Laboratories
$15,113
Eli Lilly and Company
$14,700
Boehringer Ingelheim Pharmaceuticals, Inc.
$14,142
Janssen Scientific Affairs, LLC
$13,390
AstraZeneca UK Limited
$12,159
Mallinckrodt Hospital Products Inc.
$10,800
Janssen Research & Development, LLC
$10,000
Instrumentation Laboratory Company
$6,328
Aegerion Pharmaceuticals, Inc.
$6,044
BAXTER HEALTHCARE
$5,996
Boehringer Ingelheim International GmbH
$5,470
Quidel Corporation
$4,943
Mallinckrodt Enterprises LLC
$3,741
Chiesi USA, Inc.
$3,653
Rockwell Medical, Inc.
$3,000
Regeneron Pharmaceuticals, Inc.
$2,758
Esperion Therapeutics, Inc.
$2,394
CHF Solutions, Inc
$2,121
Novartis Pharma AG
$1,255
Medicure Pharma Inc.
$701
Boehringer Ingelheim Pharma GmbH & Co.KG
$630
Keryx Biopharmaceuticals, Inc.
$450
Novartis Pharmaceuticals Corporation
$419
Merck Sharp & Dohme LLC
$333
E.R. Squibb & Sons, L.L.C.
$250
Corium, LLC
$225
Amarin Pharma Inc.
$205
GE Healthcare
$133
Amicus Therapeutics, Inc.
$79
Alnylam Pharmaceuticals Inc.
$77
Lexicon Pharmaceuticals, Inc.
$64
Potrero Medical, Inc.
$50
ABBVIE INC.
$47
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
ABIOMED
$37
GlaxoSmithKline, LLC.
$35
Corcept Therapeutics
$33
Amryt Pharma Holdings Ltd
$25
Takeda Pharmaceuticals U.S.A., Inc.
$22
IDORSIA PHARMACEUTICALS US INC
$17
Azurity Pharmaceuticals, Inc.
$16
Lantheus Medical Imaging, Inc.
$16
PFIZER INC.
$12
Top 3 companies account for 41.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACZ885M · AREXVY · Aquadex · Architect CK-MB · Architect system · Auryxia · Azstarys · BELSOMRA · BRILINTA · CAMZYOS · CHANTIX · CardioMEMS HF System · Corlanor · DEFINITY · EDARBYCLOR · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · GALAFOLD · GZ402671 · HeartMate · INVOKANA · Impella · JARDIANCE · JUXTAPID · Juxtapid · KENGREAL · Kerendia · Korlym · LEQVIO · LOKELMA · LifeVest · MOUNJARO · NEXLETOL · NEXLIZET · NXSTAGE SYSTEM ONE · Non-Covered · ONPATTRO · Otezla · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QULIPTA · QUVIVIQ · RYBELSUS · Renal - PD · Repatha · Rybelsus · STEGLATRO · SYSTEM ONE · System One · TRELEGY ELLIPTA · TRIFERIC · TRINTELLIX · TZIELD · UBRELVY · VERQUVO · VISIPAQUE · Vascepa · Victoza · Wegovy · XARELTO · ZYPITAMAG · ZYPITAMAG (pitavastatin)
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a cardiovascular disease specialist in Dallas?
Compare cardiologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists in nearby ZIP areas
292
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McCullough is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McCullough experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. McCullough performed 22 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McCullough receive payments from pharmaceutical companies?
Yes. Dr. McCullough received a total of $969,658 from 60 companies across 1,069 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCullough's costs compare to other cardiologists in Dallas?
Dr. McCullough's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. McCullough) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Cardiologists in Dallas
Browse cardiologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →